Belgium· BE-AMP-SAM490506-00
Advate 1000 IU
A medicinal product containing octocog alfa, registered in Belgium by Takeda Austria.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Octocog Alfa
- Manufacturer
- Takeda Austria
- Country
- Belgium (BE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Octocog alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainADVATE 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLETakeda Manufacturing Austria Ag
- SwedenADVATE 1000 IE (2 ml) Pulver och vätska till injektionsvätska, lösningTakeda Manufacturing Austria AG
- FinlandHelixate NexgenBayer AG
- NorwayAdvateTakeda Manufacturing Austria AG
- SwitzerlandAdvate 1000 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer InjektionslösungTakeda Pharma AG
- CzechiaADVATETakeda Manufacturing Austria AG, Vídeň
- United KingdomAdvate 1,000unit powder and solvent for solution for injection vialsTakeda UK Ltd
- IrelandAdvate 1000 IU/2 ml powder and solvent for solution for injectionTakeda Manufacturing Austria AG
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Recombinate
- Iceland · Advate, Kovaltry
- Italy · Recombinate
- Liechtenstein · Advate, Kovaltry
- Lithuania · Recombinate
- Netherlands · Recombinate
- Norway · Advate, Kovaltry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/27fd5bb9-0cdc-4d87-8344-b6ef6d7fd1aa GET /v1/drugs/27fd5bb9-0cdc-4d87-8344-b6ef6d7fd1aa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Advate 1000 IU",
"name_fr": "Advate 1000 IU",
"name_nl": "Advate 1000 IU",
"amp_code": "SAM490506-00",
"strengths": [
"1000.0000"
],
"pack_count": 0,
"substances": [
"Octocog Alfa"
],
"medicine_type": "ALLOPATHIC",
"atc_description": null,
"authorisation_numbers": null
}See everything about octocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.